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of amino acid residues has, in this instance, led to the
development of a surprisingly mild phenotype. This is in
direct contrast to a number of cases in which a much
smaller genetic lesion has led to the development of per-
sistently severe EBS-DM (Cummins et al, 2001).
The alignment of six individual-type 2 keratins (KRT 1, 3,
4, 5, 7, 8) showed that the RNKLA motif is poorly conserved
across these 6 individual proteins, with only lysine (K) at
codon 431 being absolutely conserved. A review of the lit-
erature shows that no EBS-causing mutations have been
reported between codons 429 and 433 in KRT5. On the
basis of this information, it is possible that this region does
not play an important functional role, such that the mutation
seen in this family may not cause significant disruption
to normal intermediate filament assembly and function, at
least later in life.
Analysis of this region indicates that this region is able to
accommodate the helical interruption within a small region
of the protein (North et al, 1994). Even though the loss of five
amino acids from an exon is a significant genetic lesion, it is
possible in this case that the location of the lesion (in an
area of low sequence conservation that has been shown to
be able to accommodate other helical disruptions) and the
form of the mutation (the mutation is in-frame and does not
affect the downstream translation of the exon) contribute to
reducing the effect of the deletion and result in the expres-
sion of a mild disease phenotype.
The greater significance of the qPCR data in this case is
unknown; however, the finding that the mutant allele is
present (at the RNA level) in the cell at 2.7 times the level of
the normal allele disproved our initial hypothesis that the
disease phenotype was mild due to lack of mutant allele
expression. Further investigation into the effect of the ab-
normal mutant allele mRNA level identified may assist in
delineating the correlation between genotype and pheno-
type, which continues to increase in complexity as more novel
EBS mutations of this nature are identified and reported.
M. W. Kemp,z S. Klingberg,w L. Lloyd,w T. J. Molloy,z P. Marr,y
Y. Wang,z G. A. C. Murrell,z and D. F. Murrell
Department of Dermatology, The St George Hospital Campus, Uni-
versity of New South Wales, Sydney, NSW, Australia; wDepartment of
Chemical Pathology, Queensland Health Pathology Service, Royal
Brisbane Hospital Campus, QLD, Australia; zOrthopaedic Research
Institute, The St George Hospital Campus, University of New South
Wales, Sydney, NSW, Australia; yDepartment of Anatomical Pathology,
St George Hospital, Sydney, NSW, Australia
DOI: 10.1111/j.0022-202X.2005.23739.x
Manuscript received August 2, 2004; revised December 17, 2004;
accepted for publication January 12, 2005
Address correspondence to: De´de´e Murrell, MD, Department of
Dermatology, The St George Hospital, Kogarah, Sydney, NSW 2217,
Australia. Email: d.murrell@unsw.edu.au
References
Cummins RE, Klingberg S, Wesley J, Rogers M, Zhao Y, Murrell DF: Keratin 14
point mutations at codon 119 of helix 1A resulting in different
epidermolysis bullosa simplex phenotypes. J Invest Dermatol 117:
1103–1107, 2001
Fine JD, Bauer EA, Briggaman RA, et al: Revised clinical and laboratory criteria
for subtypes of inherited epidermolysis bullosa. J Am Acad Dermatol
24:119–135, 1991
Fine JD, Eady RAJ, Bauer EA, et al: Revised classification system for inherited
epidermolysis bullosa; Report of the second international consensus
meeting on diagnosis and classification of epidermolysis bullosa. J Am
Acad Dermatol 42:1051–1066, 2000
Irvine AD, McLean WHI: Human keratin diseases: The increasing spectrum of
disease and subtlety of the phenotype–genotype correlation. Br J De-
rmatol 140:815–828, 1999
Ishida-Yamamoto A, McGrath JA, Chapman SJ, et al: Epidermolysis bullosa
simplex (Dowling–Meara type) is a genetic disease characterized by an
abnormal keratin-filament network involving keratins K5 and K14. J Invest
Dermatol 97:959–968, 1991
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real
time quantitative PCR and the 2DDCt Method. Methods 25:402–408, 2001
North ACT, Steinert PM, Parry DAD: Colied coil and link segments in keratin and
other intermediate filament molecules: A computer modeling study. Pro-
teins 20:174–184, 1994
Pulkkinnen L, Uitto J: Mutation analysis and molecular genetics of epidermolysis
bullosa. Matrix Biol 18:29–42, 1999
Stephens K, Ehrlich P, Weaver M, Le R, Spencer A, Sybert VP: Primers for exon
specific amplification of the KRT5 gene; identification of novel and re-
current mutations in epidermolysis bullosa simplex patients. J Invest De-
rmatol 108:349–353, 1997
Vassar R, Coulombe PA, Degenstein L, et al: Mutant keratin expression in
transgenic mice causes marked abnormalities resembling a human ge-
netic skin disease. Cell 64:365–380, 1991
Single Nucleotide Polymorphisms of the Fibroblast Growth Factor
Receptor 2 Gene in Patients with Chronic Venous Insufﬁciency
with Leg Ulcer
To the Editor:
Chronic, non-healing leg ulcers, frequently attributed to
chronic venous insufficiency result in an enormous de-
crease in the quality of patients’ life. Several factors are
suspected to play a role in the pathomechanism of pro-
longed wound healing in these patients, but the exact
pathogenesis of the disease is still unknown (Stucker et al,
2003). In this study, we aimed to identify single nucleotide
polymorphism (SNP) in the fibroblast growth factor
receptor-2 (FGFR-2) gene that might contribute to the
pathogenesis of prolonged wound healing in leg ulcer
patients.
Abbreviations: BEK, bacterially expressed kinase; CVI, chronic ve-
nous insufficiency; FGF, fibroblast growth factor; FGFR, fibroblast
growth factor receptor; KGFR, keratinocyte growth factor receptor;
SNP, single nucleotide polymorphism; UTR, untranslated region
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Early in healing wound, the production of FGF (e.g. ker-
atinocyte growth factors 1 and 2, KGF-1¼FGF-7 and KGF-
2¼FGF-10) is induced in dermal cells and the produced
KGF have a potent mitogenic effect on keratinocytes and
thus on re-epithelization (Maas-Szabowski et al, 2001). FGF
mediate their effects through binding to transmembrane ty-
rosine kinase receptors, FGFR-1, FGFR-2, FGFR-3, and
FGFR-4. The complexity of FGFR-2 is increased by mutually
exclusive alternative splicing (Oldridge et al, 1999), leading
to keratinocyte growth factor receptor (KGFR) and bacte-
rially expressed kinase (BEK), both playing important roles
in normal wound healing. BEK, predominantly expressed in
mesenchymal cells, has a wide ligand binding capacity.
KGFR, which is mainly expressed in epithelial cells, specif-
ically binds FGF-1, KGF-1, KGF-2, and FGF-22 (Baraniak
et al, 2003; Yeh et al, 2003). Altered reactivity of fibroblasts
from diabetic leg ulcers to bFGF, compared with normal
fibroblasts (Loot et al, 2002), and the reported role of bFGF
in endothelial dysfunction (Bauters et al, 1999) indicate that
FGF and their receptors might play a role in the patho-
mechanism of leg ulcers.
To date, only 10% of the identified 509 SNP of the FGFR-
2 gene, responsible for the development of craniosynos-
tosis syndromes, have been studied (McIntosh et al, 2000;
Kan et al, 2002). In order to identify SNP, which may have a
role in the pathomechanism of prolonged wound healing in
patients with leg ulcer, we have investigated five SNP of the
FGFR-2 gene, chosen from the electronic database infor-
mation of Applied Biosystems (Foster City, California),
whose possible biological effects have not yet been de-
scribed. Eighty-four percent of the so far identified 509 SNP
of FGFR-2 gene are located in introns, at sites that we be-
lieve may not influence FGFR-2 gene function. From the
remaining 16%, we have selected the five examined SNP
listed in Table I.
Altogether 82 chronic venous insufficiency (CVI) patients
with the presence of leg ulcer for more than 6 wk partic-
ipated in the study. The average duration of ulcers was 5.84
y and 24.2% of the leg ulcer patients had deep vein throm-
bosis previously. Patients with arterial diseases and diabe-
tes were excluded from the study. The 82 control individuals
were checked for CVI, arterial insufficiency, blood pressure,
and joint abnormalities and none of them showed any of
these problems. The male/female ratio was 58 of 24 among
leg ulcer patients and 38 of 44 among healthy individuals.
The average age of leg ulcer patients was 66  8.6 y,
whereas among healthy individuals, it was 50  7.4 y. In-
formed consents approved by internal review board were
obtained from all donors, and the study was conducted
according to Declaration of Helsinki Principles.
DNA was isolated from blood by a standard proteinase K
digestion method (Eppendorf AG, Hamburg, Germany).
PCR-based Assay-on-Demand SNP analysis was carried
out for the selected five SNP of the FGFR-2 gene (Applied
Biosystems). After PCR reaction, end point detection was
performed by an ABI Prism 7000 HT Sequence Detection
System (Applied Biosystems). Statistical significance was
determined by w2 probe. Between the 82 leg ulcer patients
and the 82 controls, a significant difference (w2 test
p¼0.0103) was found in the allelic distribution of the 30
untranslated region (UTR) SNP (Fig 1). The ratio of hetero-
zygotes was 53.66% in leg ulcer patients and 45.12% in the
control group, the ratio of the homozygote mutants differed
considerably in the two groups: it was 23.17% in leg ulcer
patients and 13.42% in healthy population. Of the 23.17%
homozygotes with leg ulcer (19 individuals), 10 were fe-
males and nine males, four of whom had deep vein throm-
bosis previously. The genetic variants of the 30 UTR SNP are
in Hardy–Weinberg equilibrium according to our calculation,
suggesting that the appearance of this SNP did not influ-
ence the natural selection of the population. This is also
supported by the facts that leg ulcer develops mainly in the
elderly over their active, reproductive period and aging is
involved in the etiology of prolonged wound healing. Sta-
tistical corrections (Bonferroni p¼0.0515; False Discovery
Rate Determination p¼ 0.0515) for the multiple hypothesis
of five different SNP resulted in marginal p values. In the
other four examined SNP, there were no significant allele
distribution differences between the two groups (Fig 2).
Accumulating evidence suggests that genetic variations
in the 30UTR of several genes play a role in the pathomech-
anism of various diseases via altering the stability of the
primary mRNA, thus decreasing or increasing the expres-
sion of the final protein product (Di Paola et al, 2002;
Vasilopoulos et al, 2004). Here, we show the significantly
higher appearance of an SNP in the 30 UTR of FGFR-2 gene
among leg ulcer patients relative to healthy controls. We
hypothesize that this SNP of the 30 UTR might alter the
stability of the mRNA transcripts of the FGFR-2 gene, re-
sulting in decreased amounts of KGFR and/or BEK proteins,
altering either re-epithelization (Maas-Szabowski et al,
2001) and/or repair-associated angiogenic processes (Au-
guste et al, 2001; Shan et al, 2004).
Complex diseases like leg ulcer are attributed to the
interference of multiple environmental factors and to a
polygenic background. Recently, several candidate gene
Table I. Description of the examined FGFR-2 SNP
Location in FGFR-2 gene Exact positiona Possible alteration in gene function ID number in applied database
Promoter 2753T ! C Transcription activity C__12126064_10
Exon 5 103A ! G Thr ! Met C__2414603_10
Intron 6 91C ! T Splicing C__2917358_1_
Exon 6 64C ! T Val ! Val C__8899692_1_
30 UTR 2451A ! G mRNA stability C__2917245_10
aAccording to the public sequence of FGFR-2 gene in NCBI (Acc. No.: AF360695).
FGFR-2, fibroblast growth factor receptor-2; SNP, single nucleotide polymorphism; UTR, untranslated region.
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polymorphisms associated with diabetic neuropathy and
leg ulcer have been reported (Raccah et al, 2004). Munkvad
and Jorgensen (1996) demonstrated that an autosomal
dominantly inherited defect in the anticoagulant system,
namely resistance to activated protein C (APC-resistance),
is a significant risk factor, not only for venous thrombosis
but for the development of venous leg ulcer as well. Our
study reports on a genetic alteration of FGFR-2 gene with
significantly higher appearance in CVI patients with chronic
non-healing wounds. The possibility that this SNP is related
to CVI susceptibility itself and not to the impaired wound
healing will be determined in further studies, in which CVI
patients with and without leg ulcers will be compared. Since
reproducibility is a very serious concern in association
studies, we are not declaring a true genetic association in
this report between the 30 UTR SNP of FGFR-2 and venous
ulcers yet. To do so, further studies in larger populations
are needed.
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Figure 1
Distribution of the three possible 30 untranslated region (UTR) sin-
gle nucleotide polymorphism (SNP) genotypes of fibroblast growth
factor receptor-2 (FGFR-2) gene. Among the 164 examined individ-
uals, that of heterozygotes was 49.39%, that of homozygote mutants
was 18.29% and that of homozygote wild-types was 32.32%. (a)
Among patients with leg ulcer (n¼82), the proportion of heterozygotes
was 53.66%, and that of both homozygote mutants and homozygote
wild-types was 23.17%. (b) Among members of the control group
(n¼ 82), the proportion of the heterozygotes was 45.12%, that of ho-
mozygote mutants was 13.42%, and that of homozygote wild-types
was 41.46%. The homozygote mutant genotype of the examined 30
UTR SNP of FGFR-2 gene showed an incidence nearly twice higher
among leg ulcer patients than among healthy individuals. Thus, the
distribution of genotypes showed significant difference between leg
ulcer patients and healthy individuals (w2 test p¼ 0.0103).
Figure2
Mutant allele frequencies of the examined five single nucleotide
polymorphisms (SNP). Results are devided into five groups according
to the five examined SNP. In each group, the dark bar symbolizes the
frequency of the mutant allele measured among patients with leg ulcer
(n¼82) and the light bar symbolizes the frequency of the mutant allele
measured among members of the control group (n¼82). According to
our results, the SNP located in 30 untranslated region (UTR) of the
mRNA showed significant difference in the mutant allele distribution
between patients suffering from leg ulcer and members of the control
group (w2 test p¼0.0103). Statistical corrections (Bonferroni p¼
0.0515; False Discovery Rate Determination p¼ 0.0515) for the multi-
ple hypothesis of five different SNP resulted in marginal p values. Con-
cerning the other four SNP, situated in the promoter region, exon 5,
exon 6, and intron 6, there were no significant differences in the dis-
tribution of the mutant allele between the two groups.
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Increased Serum CCL28 Levels in Patients with Atopic Dermatitis,
Psoriasis Vulgaris and Bullous Pemphigoid
To the Editor:
Atopic dermatitis is an inflammatory skin disease that is
characterized by pruritic and eczematous lesions persisting
chronically. Histopathologically, the skin lesions in atopic
dermatitis show infiltration of T lymphocytes, especially cu-
taneous lymphocyte antigen-positive memory T cells, as
well as eosinophils and macrophages (Novak et al, 2003).
Previous studies revealed that increased amounts of thy-
mus and activation-regulated chemokine (CCL17) and cu-
taneous T cell-attracting chemokine (CTACK)/CCL27 were
detected in the serum and lesional keratinocytes of patients
with atopic dermatitis (Kakinuma et al, 2001, 2003). These
results suggest involvement of these chemokines in the
pathogenesis of this disease.
Psoriasis vulgaris is also a chronic and relapsing inflam-
matory skin disease characterized as a T cell-mediated au-
toimmune disorder (Chang, 1992). CTACK/CCL27 was
strongly detected in the serum and lesional keratinocytes
of patients with psoriasis vulgaris (Kakinuma et al, 2003). It
has been proposed that interaction between T cells and
epidermal keratinocytes plays a central role in the patho-
genesis of psoriasis vulgaris (Chang, 1992).
Bullous pemphigoid is a blistering autoimmune skin dis-
ease. It often provokes lesional eosinophil infiltration (Pier-
ard et al, 1961). Eotaxin/CCL11 was strongly detected in
blister fluid of bullous pemphigoid and strongly expressed in
keratinocytes around blisters of this disease (Wakugawa
et al, 2000).
Mucosae-associated epithelial chemokine (MEC)/CCL28
is a novel chemokine ligand for CC chemokine receptor
(CCR) 10 and CCR3 (Pan et al, 2000). MEC/CCL28 is most
homologous to CTACK/CCL27, displaying about 40% iden-
tity, and is most abundant in the salivary gland, with strong
expression in other tissues associated with mucosal epi-
thelial surfaces, including colon, trachea, and mammary
gland. MEC/CCL28 attracts subsets of memory lymph-
ocytes and eosinophils (Pan et al, 2000). Wang et al (2000)
showed that MEC/CCL28 mRNA was expressed predom-
inantly in psoriasis patient skin samples and to a lesser
degree in healthy human skin. But MEC/CCL28 production
at protein levels in skin is totally unknown. Furthermore,
there has been no report of serum MEC/CCL28 levels in
patients with skin diseases. This prompted us to investigate
the relationship between MEC/CCL28 and skin diseases.
Therefore, we examined serum MEC/CCL28 levels of
patients with atopic dermatitis, psoriasis vulgaris, and
bullous pemphigoid. Furthermore, in order to determine
which cells produced MEC/CCL28 in skin, we performed
Figure1
Serum CCL28 levels. Serum mucosae-associated epithelial chemo-
kine (MEC)/CCL28 levels in patients with atopic dermatitis (AD), pso-
riasis vulgaris (PsV), bullous pemphigoid (BP), and healthy controls
(Control). Data are presented as mean  standard error.
Abbreviations: CCR, CC chemokine receptor; CTACK, cutaneous T
cell-attracting chemokine; MEC, Mucosae-associated epithelial
chemokine
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